India’s SARS-CoV-2 Genomics Consortium (INSACOG), confirmed in a press release on Sunday the presence of Omicron’s BA.4 and BA.5 subvariants in India.
BA.4 and BA.5 are sub-variants of Omicron circulating around the world. Omicron BA.4 and BA.5 variants have been linked to the fifth wave of Covid in South Africa and recently the US and Europe have also reported.
INSACOG is launched jointly by the Union Ministry of Health and Department of Biotechnology (DBT) with the Council for Scientific and Industrial Research (CSIR) and the Indian Council of Medical Research (ICMR).
India’s first case of Omicron strain BA.4 sub-variant of coronavirus detected in Hyderabad through genomic surveillance program
The INSACOG press release gave details of the cases detected in India.
He mentioned that a 19-year-old girl from Tamil Nadu was found infected with the BA.4 variant of SARS-CoV-2.
“The patient showed only mild clinical symptoms and was fully vaccinated. The patient had no travel history.” the statement confirmed.
The consortium also informed that a traveler to South Africa also tested positive for Omicron’s BA.4 subvariant. “A South African traveler was reported positive for the BA.4 variant upon arrival at Hyderabad Airport”.
See the INSACOG update here
In addition, INSACOG also informed that an 80-year-old man in Telangana tested positive for the BA.% subvariant of Omicron. “The patient showed only mild clinical symptoms and was fully vaccinated. The patient had no travel history,” the statement read.
The agency has also begun contact tracing of BA.4 and BA.5 patients as a precaution.
India recorded 2,226 new coronavirus infections on Sunday, taking the total number of Covid-19 cases to 4, 31, 36,371, while active cases fell to 14,955, health ministry data shows. of the Union.
Cases of the BA.4 subvariant were first reported in South Africa on January 10, 2022, now accounting for 35% of positive tests. BA.5 was identified on February 25 and now accounts for 20% of cases in several southern countries. African regions.
BA.4 and BA.5 have been identified in several countries in addition to South Africa. According to a report by the UK Health Security Agency (UKHSA), with data up to April 22, BA.4 was present in Austria, UK, USA, Denmark, Belgium, Israel , Germany, Italy, Canada, France, Netherlands, Australia, Switzerland and Botswana.
By the same date, health authorities had identified BA.5 in Portugal, Germany, United Kingdom, United States, Denmark, France, Austria, Belgium, Hong Kong, Australia, Canada , Israel, Norway, Pakistan, Spain and Switzerland.
Few countries sequence large numbers of positive tests, although the director-general of the World Health Organization (WHO) told Trusted Source on May 4 that “testing and sequencing remain absolutely essential.”